Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

During Conf Call, Charles River Exec Reportedly Says Effects Of Government Funding Reductions, Including At NIH Have Been Minimal; A Top Priority In Coming Years Will Be To Continue Expanding Portfolio Of NAMs Through Partnerships, Selective M&A And Internal Development; Expects Loss Of Commercial CDMO Revenue Will Reduce Manufacturing Solutions Growth Rate By Less Than 500 Basis Points For 2025

Author: Benzinga Newsdesk | August 06, 2025 09:27am

Posted In: CRL